Doctors Note Logo

Published on: 9/23/2026

What are the side effects of the RSV vaccine?

Common RSV vaccine side effects include injection site pain, redness or swelling, fatigue, headache, muscle or joint aches, and sometimes a low-grade fever, and most resolve within a few days. Less common but more serious reactions have been reported, including allergic reactions and rare neurologic events such as Guillain-Barré syndrome, so timing, age, pregnancy status, and your health history all matter. There are several important factors to consider before and after vaccination, including which RSV vaccine you received and which symptoms warrant prompt medical attention. See below to understand more about how long side effects typically last, how to ease them safely, and the warning signs that are not normal.

If you are feeling unwell after an RSV vaccine and are unsure whether it is a routine reaction or something that needs care, a free, instant, online symptom check can help you compare your symptoms against thousands of conditions in minutes, clarify what is likely happening, and show you whether to rest at home, call your clinician, or seek urgent care right away.

Last reviewed for medical accuracy: 09/23/2025

answer background

Explanation

RSV Vaccine Side Effects: What You Need to Know

Respiratory Syncytial Virus (RSV) can cause serious respiratory infections, especially in infants, older adults, and people with weakened immune systems. Vaccination against RSV offers significant protection, but like any medical intervention, it carries potential side effects. Understanding these rsv vaccine side effects can help you make an informed decision and manage any discomfort that might arise.

Overview of RSV Vaccines

Several RSV vaccines have been authorized for use in older adults and pregnant individuals to protect newborns through transferred antibodies. Clinical trials and post-marketing surveillance provide data on safety and tolerability. Most people experience only mild reactions that resolve quickly.

Common rsv vaccine side effects

These reactions are the most frequently reported. They typically appear within a day of vaccination and last one to three days.

  • Pain at the injection site
    • Mild to moderate soreness or tenderness
    • Possible redness or swelling
  • Fatigue
    • Tiredness or low energy
  • Muscle aches
    • Generalized body stiffness or soreness
  • Headache
    • Mild to moderate discomfort
  • Fever
    • Low-grade fever (usually under 100.4°F / 38°C)
  • Chills
    • Shivering or feeling cold despite normal temperature
  • Nausea
    • Mild stomach discomfort or queasiness

Less common rsv vaccine side effects

These occur in a smaller percentage of vaccine recipients. They may require simple at-home remedies.

  • Swollen lymph nodes (particularly in the arm or neck)
  • Joint pain
  • Irritability or mood changes
  • Loss of appetite
  • Mild rash

Rare but serious rsv vaccine side effects

Serious complications are very uncommon. Vaccine trials and monitoring systems show these events occur in fewer than one in several thousand people.

  • Allergic reactions (anaphylaxis)
    • Symptoms: hives, difficulty breathing, swelling of face or throat, rapid heartbeat
    • Onset: usually within minutes to a few hours after vaccination
  • Severe neurologic events (very rare)
    • Guillain-Barré syndrome: muscle weakness, tingling sensations beginning in the legs
  • High fever (over 104°F / 40°C)
  • Severe injection-site reactions
    • Excessive swelling, redness spreading beyond two inches, extreme pain

If you experience any of these serious signs, seek immediate medical attention.

Managing common side effects

Most rsv vaccine side effects are mild and manageable at home with these steps:

  • Apply a cool, damp cloth to the injection area to reduce pain and swelling.
  • Over-the-counter pain relievers (acetaminophen or ibuprofen) can help with fever and aches. Follow dosing guidelines or talk to a pharmacist.
  • Rest and hydrate: Drink plenty of fluids and allow your body time to recover.
  • Gentle movement: If you feel stiff, light stretching or a short walk can ease muscle aches.
  • Dress comfortably: Loose clothing around the injection site can reduce irritation.

When to seek medical attention

While most reactions are mild, contact your healthcare provider or seek emergency care if you experience:

  • Signs of an allergic reaction: hives, swelling of face or throat, difficulty breathing
  • High fever lasting more than 48 hours
  • Severe headache, stiff neck, confusion, or persistent vomiting
  • Redness or swelling at the injection site that worsens after 24 hours
  • Any symptom that feels sudden, severe, or life-threatening

Checking your symptoms online

If you’re unsure whether your symptoms are normal or you need professional advice, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you decide whether to seek immediate medical care or manage your symptoms at home.

Balancing benefits and risks

The primary goal of RSV vaccination is to prevent severe illness, hospitalizations, and even death related to RSV infection. While rsv vaccine side effects can be uncomfortable, the risk of serious disease often outweighs these temporary reactions. Discuss your individual risk profile—age, underlying health conditions, pregnancy status—with your doctor to decide if RSV vaccination is right for you.

Tips for a smooth vaccination experience

  • Schedule wisely: Plan your vaccination when you can rest afterward.
  • Stay hydrated: Drink extra fluids before and after your appointment.
  • Know your history: Share any past vaccine reactions with your healthcare provider.
  • Ask questions: Discuss concerns about side effects and get clear guidance on when to follow up.

Speak to a doctor

Your health is unique. If you have questions about rsv vaccine side effects, underlying conditions, or whether the vaccine fits your situation, speak to a doctor. They can provide personalized advice, evaluate any potential risks, and guide you through the decision-making process.


This information is intended to help you understand the possible side effects of the RSV vaccine and how to handle them. Always reach out to a medical professional if you encounter anything serious or life-threatening. Your healthcare provider is the best resource for tailored, evidence-based guidance.

(References)

  • * Qiu X, Xu S, Lu Y, Luo Z, Yan Y, Wang C, Ji J. Development of mRNA vaccines against respiratory syncytial virus (RSV). Cytokine Growth Factor Rev. 2022 Dec;68:37-53. doi: 10.1016/j.cytogfr.2022.10.001. Epub 2022 Oct 13. PMID: 36280532.

  • * Papi A, Ison MG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Campora L, Dezutter N, de Schrevel N, Fissette L, David MP, Van der Wielen M, Kostanyan L, Hulstrøm V, AReSVi-006 Study Group. Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults. N Engl J Med. 2023 Feb 16;388(7):595-608. doi: 10.1056/NEJMoa2209604. PMID: 36791160.

  • * Walsh EE, Pérez Marc G, Zareba AM, Falsey AR, Jiang Q, Patton M, Polack FP, Llapur C, Doreski PA, Ilangovan K, Rämet M, Fukushima Y, Hussen N, Bont LJ, Cardona J, DeHaan E, Castillo Villa G, Ingilizova M, Eiras D, Mikati T, Shah RN, Schneider K, Cooper D, Koury K, Lino MM, Anderson AS, Jansen KU, Swanson KA, Gurtman A, Gruber WC, Schmoele-Thoma B, RENOIR Clinical Trial Group. Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults. N Engl J Med. 2023 Apr 20;388(16):1465-1477. doi: 10.1056/NEJMoa2213836. Epub 2023 Apr 5. PMID: 37018468.

  • * Kampmann B, Madhi SA, Munjal I, Simões EAF, Pahud BA, Llapur C, Baker J, Pérez Marc G, Radley D, Shittu E, Glanternik J, Snaggs H, Baber J, Zachariah P, Barnabas SL, Fausett M, Adam T, Perreras N, Van Houten MA, Kantele A, Huang LM, Bont LJ, Otsuki T, Vargas SL, Gullam J, Tapiero B, Stein RT, Polack FP, Zar HJ, Staerke NB, Duron Padilla M, Richmond PC, Koury K, Schneider K, Kalinina EV, Cooper D, Jansen KU, Anderson AS, Swanson KA, Gruber WC, Gurtman A, MATISSE Study Group. Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. 2023 Apr 20;388(16):1451-1464. doi: 10.1056/NEJMoa2216480. Epub 2023 Apr 5. PMID: 37018474.

  • * Ison MG, Papi A, Athan E, Feldman RG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Verheust C, Dezutter N, Gruselle O, Fissette L, David MP, Kostanyan L, Hulstrøm V, Olivier A, Van der Wielen M, Descamps D, AReSVi-006 Study Group. Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons. Clin Infect Dis. 2024 Jun 14;78(6):1732-1744. doi: 10.1093/cid/ciae010. PMID: 38253338; PMCID: PMC1175669.

  • * Phijffer EW, de Bruin O, Ahmadizar F, Bont LJ, Van der Maas NA, Sturkenboom MC, Wildenbeest JG, Bloemenkamp KW. Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes. Cochrane Database Syst Rev. 2024 May 2;5(5):CD015134. doi: 10.1002/14651858.CD015134.pub2. Epub 2024 May 2. PMID: 38695784; PMCID: PMC11064886.

  • * Roman F, Burny W, Ceregido MA, Laupèze B, Temmerman ST, Warter L, Coccia M. Adjuvant system AS01: from mode of action to effective vaccines. Expert Rev Vaccines. 2024 Jan-Dec;23(1):715-729. doi: 10.1080/14760584.2024.2382725. Epub 2024 Aug 5. PMID: 39042099.

  • * Simões EAF, Pahud BA, Madhi SA, Kampmann B, Shittu E, Radley D, Llapur C, Baker J, Pérez Marc G, Barnabas SL, Fausett M, Adam T, Perreras N, Van Houten MA, Kantele A, Huang LM, Bont LJ, Otsuki T, Vargas SL, Gullam J, Tapiero B, Stein RT, Polack FP, Zar HJ, Staerke NB, Padilla MD, Richmond PC, Sarwar UN, Baber J, Koury K, Lino MM, Kalinina EV, Li W, Cooper D, Anderson AS, Swanson KA, Gurtman A, Munjal I, MATISSE (Maternal Immunization Study for Safety and Efficacy) Clinical Trial Group. Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial. Obstet Gynecol. 2025 Feb 1;145(2):157-167. doi: 10.1097/AOG.0000000000005816. Epub 2025 Jan 2. PMID: 39746212; PMCID: PMC11731064.

  • * Kelleher K, Subramaniam N, Drysdale SB. The recent landscape of RSV vaccine research. Ther Adv Vaccines Immunother. 2025;13:25151355241310601. doi: 10.1177/25151355241310601. Epub 2025 Jan 10. PMID: 39802673; PMCID: PMC11724408.

  • * Scott J, Abers MS, Marwah HK, McCann NC, Meyerowitz EA, Richterman A, Fleming DF, Holmes EJ, Moat LE, Redepenning SG, Smith EA, Stoddart CJ, Sundaram ME, Ulrich AK, Alba C, Anderson CJ, Arpey MK, Borre E, Ladines-Lim J, Mehr AJ, Rich K, Watts C, Basta NE, Jarolimova J, Walensky RP, Dugdale CM. Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026. N Engl J Med. 2025 Dec 4;393(22):2221-2242. doi: 10.1056/NEJMsa2514268. Epub 2025 Oct 29. PMID: 41160817.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.